181 related articles for article (PubMed ID: 1692997)
1. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
[TBL] [Abstract][Full Text] [Related]
2. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Wald N; Cuckle H; Nanchahal K
Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
[TBL] [Abstract][Full Text] [Related]
3. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
[TBL] [Abstract][Full Text] [Related]
4. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
[TBL] [Abstract][Full Text] [Related]
6. The use of amniotic fluid AFP action limits in diagnosing open neural tube defects.
Brock DJ
Prenat Diagn; 1981 Jan; 1(1):11-6. PubMed ID: 6180421
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Cuckle HS; Wald NJ; Cuckle PM
Prenat Diagn; 1989 Jun; 9(6):393-400. PubMed ID: 2668917
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
[TBL] [Abstract][Full Text] [Related]
9. Cut-off levels for maternal plasma alpha-fetoprotein in the diagnosis of neural tube defects: validation of the use of multiples of the normal median.
Tovey KC; Gerson M
Br J Obstet Gynaecol; 1979 Jul; 86(7):507-15. PubMed ID: 89862
[TBL] [Abstract][Full Text] [Related]
10. Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome.
Wald NJ; Hackshaw AK; George LM
J Med Screen; 2000; 7(2):74-7. PubMed ID: 11002446
[TBL] [Abstract][Full Text] [Related]
11. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation.
Crandall BF; Chua C
Prenat Diagn; 1995 Apr; 15(4):339-43. PubMed ID: 7542382
[TBL] [Abstract][Full Text] [Related]
12. Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects.
Ghosh A; Tang MH; Tai D; Nie G; Ma HK
Prenat Diagn; 1986; 6(2):83-7. PubMed ID: 2422642
[TBL] [Abstract][Full Text] [Related]
13. Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy.
Smith AD; Wald NJ; Cuckle HS; Stirrat GM; Bobrow M; Lagercrantz H
Lancet; 1979 Mar; 1(8118):685-8. PubMed ID: 85932
[TBL] [Abstract][Full Text] [Related]
14. [Results of an experiment in systematic prenatal screening for neural tube malformations by assay of alpha fetoproteins in dried blood samples (12,480 pregnancies)].
Augier D; Sarramon MF; Rorive C; Dutau G; Sablayrolles B; Reme JM; Rochiccioli P
J Genet Hum; 1985 Sep; 33(3-4):325-36. PubMed ID: 2414398
[TBL] [Abstract][Full Text] [Related]
15. Effect of estimating gestational age by ultrasound cephalometry on the specificity of alpha-fetoprotein screening for open neural-tube defects.
Wald N; Cuckle H; Boreham J; Turnbull AC
Br J Obstet Gynaecol; 1982 Dec; 89(12):1050-3. PubMed ID: 6184069
[TBL] [Abstract][Full Text] [Related]
16. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
Barnabei VM; Krantz DA; Macri JN; Larsen JW
Prenat Diagn; 1995 Dec; 15(12):1131-4. PubMed ID: 8750293
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal alpha fetoprotein screening for defects in the neural tube].
Grob PJ
Schweiz Med Wochenschr; 1978 Aug; 108(34):1302-7. PubMed ID: 80821
[TBL] [Abstract][Full Text] [Related]
18. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein and the prenatal diagnosis of neural tube defects.
Pergament E
Obstet Gynecol Annu; 1977; 6():173-89. PubMed ID: 73159
[No Abstract] [Full Text] [Related]
20. Antenatal screening in Oxford for fetal neural tube defects.
Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
